aluates Reports

$ 0.0

Automative

Global Hormone Sensitive Prostate Cancer Drugs Market Research Report 2026

Published Date: 2026-02-04

Report Code: QYRE-Auto-26P18248

Global Hormone Sensitive Prostate Cancer Drugs Market Research Report 2024

BUY CHAPTERS

Global Hormone Sensitive Prostate Cancer Drugs Market Research Report 2026

Code: QYRE-Auto-26P18248

Report

2026-02-04

Pages:115

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Novartis

Merc & Co.

Bristol myers

Dendreon Corporation

GlaxoSmithKline PLC

Ferring

Roche

Celgen

Amgen Inc

TEVA

Bayer

Pfizer Inc

Merc & Co.

Hormone Sensitive Prostate Cancer Drugs Market Size

The global Hormone Sensitive Prostate Cancer Drugs market was valued at US$ 172 million in 2025 and is anticipated to reach US$ 343 million by 2032, at a CAGR of 10.5% from 2026 to 2032.

Hormone Sensitive Prostate Cancer Drugs Market

Hormone-sensitive prostate cancer (HSPC) drugs are a class of medications used to treat prostate cancer that is dependent on androgens, or male hormones, to grow and spread. These drugs work by reducing or blocking the production of androgens in the body, mainly testosterone, or by inhibiting androgen receptors on cancer cells. This hormonal therapy aims to slow down or stop the progression of cancer by depriving cancer cells of the hormones they need to grow. Common drugs in this category include androgen deprivation therapies (ADTs) like LHRH agonists, LHRH antagonists, and anti-androgens.

The North American market for Hormone Sensitive Prostate Cancer Drugs is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The Asia-Pacific market for Hormone Sensitive Prostate Cancer Drugs is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The global market for Hormone Sensitive Prostate Cancer Drugs in Hospitals is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.

Major global companies of Hormone Sensitive Prostate Cancer Drugs include Novartis, Merc & Co., Bristol-Myers, Dendreon Corporation, GlaxoSmithKline, Ferring, Roche, Celgen, Amgen, Teva, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.

This report delivers a comprehensive overview of the global Hormone Sensitive Prostate Cancer Drugs market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Hormone Sensitive Prostate Cancer Drugs. The Hormone Sensitive Prostate Cancer Drugs market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Hormone Sensitive Prostate Cancer Drugs market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Hormone Sensitive Prostate Cancer Drugs manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Hormone Sensitive Prostate Cancer Drugs Market Report

Report Metric	Details
Report Name	Hormone Sensitive Prostate Cancer Drugs Market
Accounted market size in 2025	US$ 172 million
Forecasted market size in 2032	US$ 343 million
CAGR	10.5%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Androgen Ablation Therapy Anti-androgens Chemotherapy Targeted Therapy
Segment by Application	Hospitals Clinics Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Novartis, Merc & Co., Bristol-Myers, Dendreon Corporation, GlaxoSmithKline, Ferring, Roche, Celgen, Amgen, Teva, Bayer, Pfizer
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Hormone Sensitive Prostate Cancer Drugs companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Hormone Sensitive Prostate Cancer Drugs Market growing?

Ans: The Hormone Sensitive Prostate Cancer Drugs Market witnessing a CAGR of 10.5% during the forecast period 2026-2032.

What is the Hormone Sensitive Prostate Cancer Drugs Market size in 2032?

Ans: The Hormone Sensitive Prostate Cancer Drugs Market size in 2032 will be US$ 343 million.

Who are the main players in the Hormone Sensitive Prostate Cancer Drugs Market report?

Ans: The main players in the Hormone Sensitive Prostate Cancer Drugs Market are Novartis, Merc & Co., Bristol-Myers, Dendreon Corporation, GlaxoSmithKline, Ferring, Roche, Celgen, Amgen, Teva, Bayer, Pfizer

What are the Application segmentation covered in the Hormone Sensitive Prostate Cancer Drugs Market report?

Ans: The Applications covered in the Hormone Sensitive Prostate Cancer Drugs Market report are Hospitals, Clinics, Other

What are the Type segmentation covered in the Hormone Sensitive Prostate Cancer Drugs Market report?

Ans: The Types covered in the Hormone Sensitive Prostate Cancer Drugs Market report are Androgen Ablation Therapy, Anti-androgens, Chemotherapy, Targeted Therapy

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Hormone Sensitive Prostate Cancer Drugs Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Androgen Ablation Therapy

1.2.3 Anti-androgens

1.2.4 Chemotherapy

1.2.5 Targeted Therapy

1.3 Market by Application

1.3.1 Global Hormone Sensitive Prostate Cancer Drugs Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Hormone Sensitive Prostate Cancer Drugs Market Perspective (2021–2032)

2.2 Global Hormone Sensitive Prostate Cancer Drugs Growth Trends by Region

2.2.1 Global Hormone Sensitive Prostate Cancer Drugs Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Hormone Sensitive Prostate Cancer Drugs Historic Market Size by Region (2021–2026)

2.2.3 Hormone Sensitive Prostate Cancer Drugs Forecasted Market Size by Region (2027–2032)

2.3 Hormone Sensitive Prostate Cancer Drugs Market Dynamics

2.3.1 Hormone Sensitive Prostate Cancer Drugs Industry Trends

2.3.2 Hormone Sensitive Prostate Cancer Drugs Market Drivers

2.3.3 Hormone Sensitive Prostate Cancer Drugs Market Challenges

2.3.4 Hormone Sensitive Prostate Cancer Drugs Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Hormone Sensitive Prostate Cancer Drugs Players by Revenue

3.1.1 Global Top Hormone Sensitive Prostate Cancer Drugs Players by Revenue (2021–2026)

3.1.2 Global Hormone Sensitive Prostate Cancer Drugs Revenue Market Share by Players (2021–2026)

3.2 Global Top Hormone Sensitive Prostate Cancer Drugs Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Hormone Sensitive Prostate Cancer Drugs Revenue

3.4 Global Hormone Sensitive Prostate Cancer Drugs Market Concentration Ratio

3.4.1 Global Hormone Sensitive Prostate Cancer Drugs Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Hormone Sensitive Prostate Cancer Drugs Revenue in 2025

3.5 Global Key Players of Hormone Sensitive Prostate Cancer Drugs Head Offices and Areas Served

3.6 Global Key Players of Hormone Sensitive Prostate Cancer Drugs, Products and Applications

3.7 Global Key Players of Hormone Sensitive Prostate Cancer Drugs, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Hormone Sensitive Prostate Cancer Drugs Breakdown Data by Type

4.1 Global Hormone Sensitive Prostate Cancer Drugs Historic Market Size by Type (2021–2026)

4.2 Global Hormone Sensitive Prostate Cancer Drugs Forecasted Market Size by Type (2027–2032)

5 Hormone Sensitive Prostate Cancer Drugs Breakdown Data by Application

5.1 Global Hormone Sensitive Prostate Cancer Drugs Historic Market Size by Application (2021–2026)

5.2 Global Hormone Sensitive Prostate Cancer Drugs Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Hormone Sensitive Prostate Cancer Drugs Market Size (2021–2032)

6.2 North America Hormone Sensitive Prostate Cancer Drugs Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Hormone Sensitive Prostate Cancer Drugs Market Size by Country (2021–2026)

6.4 North America Hormone Sensitive Prostate Cancer Drugs Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Hormone Sensitive Prostate Cancer Drugs Market Size (2021–2032)

7.2 Europe Hormone Sensitive Prostate Cancer Drugs Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Hormone Sensitive Prostate Cancer Drugs Market Size by Country (2021–2026)

7.4 Europe Hormone Sensitive Prostate Cancer Drugs Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Hormone Sensitive Prostate Cancer Drugs Market Size (2021–2032)

8.2 Asia-Pacific Hormone Sensitive Prostate Cancer Drugs Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Hormone Sensitive Prostate Cancer Drugs Market Size by Region (2021–2026)

8.4 Asia-Pacific Hormone Sensitive Prostate Cancer Drugs Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Hormone Sensitive Prostate Cancer Drugs Market Size (2021–2032)

9.2 Latin America Hormone Sensitive Prostate Cancer Drugs Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Hormone Sensitive Prostate Cancer Drugs Market Size by Country (2021–2026)

9.4 Latin America Hormone Sensitive Prostate Cancer Drugs Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Hormone Sensitive Prostate Cancer Drugs Market Size (2021–2032)

10.2 Middle East & Africa Hormone Sensitive Prostate Cancer Drugs Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Hormone Sensitive Prostate Cancer Drugs Market Size by Country (2021–2026)

10.4 Middle East & Africa Hormone Sensitive Prostate Cancer Drugs Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Novartis

11.1.1 Novartis Company Details

11.1.2 Novartis Business Overview

11.1.3 Novartis Hormone Sensitive Prostate Cancer Drugs Introduction

11.1.4 Novartis Revenue in Hormone Sensitive Prostate Cancer Drugs Business (2021–2026)

11.1.5 Novartis Recent Development

11.2 Merc & Co.

11.2.1 Merc & Co. Company Details

11.2.2 Merc & Co. Business Overview

11.2.3 Merc & Co. Hormone Sensitive Prostate Cancer Drugs Introduction

11.2.4 Merc & Co. Revenue in Hormone Sensitive Prostate Cancer Drugs Business (2021–2026)

11.2.5 Merc & Co. Recent Development

11.3 Bristol-Myers

11.3.1 Bristol-Myers Company Details

11.3.2 Bristol-Myers Business Overview

11.3.3 Bristol-Myers Hormone Sensitive Prostate Cancer Drugs Introduction

11.3.4 Bristol-Myers Revenue in Hormone Sensitive Prostate Cancer Drugs Business (2021–2026)

11.3.5 Bristol-Myers Recent Development

11.4 Dendreon Corporation

11.4.1 Dendreon Corporation Company Details

11.4.2 Dendreon Corporation Business Overview

11.4.3 Dendreon Corporation Hormone Sensitive Prostate Cancer Drugs Introduction

11.4.4 Dendreon Corporation Revenue in Hormone Sensitive Prostate Cancer Drugs Business (2021–2026)

11.4.5 Dendreon Corporation Recent Development

11.5 GlaxoSmithKline

11.5.1 GlaxoSmithKline Company Details

11.5.2 GlaxoSmithKline Business Overview

11.5.3 GlaxoSmithKline Hormone Sensitive Prostate Cancer Drugs Introduction

11.5.4 GlaxoSmithKline Revenue in Hormone Sensitive Prostate Cancer Drugs Business (2021–2026)

11.5.5 GlaxoSmithKline Recent Development

11.6 Ferring

11.6.1 Ferring Company Details

11.6.2 Ferring Business Overview

11.6.3 Ferring Hormone Sensitive Prostate Cancer Drugs Introduction

11.6.4 Ferring Revenue in Hormone Sensitive Prostate Cancer Drugs Business (2021–2026)

11.6.5 Ferring Recent Development

11.7 Roche

11.7.1 Roche Company Details

11.7.2 Roche Business Overview

11.7.3 Roche Hormone Sensitive Prostate Cancer Drugs Introduction

11.7.4 Roche Revenue in Hormone Sensitive Prostate Cancer Drugs Business (2021–2026)

11.7.5 Roche Recent Development

11.8 Celgen

11.8.1 Celgen Company Details

11.8.2 Celgen Business Overview

11.8.3 Celgen Hormone Sensitive Prostate Cancer Drugs Introduction

11.8.4 Celgen Revenue in Hormone Sensitive Prostate Cancer Drugs Business (2021–2026)

11.8.5 Celgen Recent Development

11.9 Amgen

11.9.1 Amgen Company Details

11.9.2 Amgen Business Overview

11.9.3 Amgen Hormone Sensitive Prostate Cancer Drugs Introduction

11.9.4 Amgen Revenue in Hormone Sensitive Prostate Cancer Drugs Business (2021–2026)

11.9.5 Amgen Recent Development

11.10 Teva

11.10.1 Teva Company Details

11.10.2 Teva Business Overview

11.10.3 Teva Hormone Sensitive Prostate Cancer Drugs Introduction

11.10.4 Teva Revenue in Hormone Sensitive Prostate Cancer Drugs Business (2021–2026)

11.10.5 Teva Recent Development

11.11 Bayer

11.11.1 Bayer Company Details

11.11.2 Bayer Business Overview

11.11.3 Bayer Hormone Sensitive Prostate Cancer Drugs Introduction

11.11.4 Bayer Revenue in Hormone Sensitive Prostate Cancer Drugs Business (2021–2026)

11.11.5 Bayer Recent Development

11.12 Pfizer

11.12.1 Pfizer Company Details

11.12.2 Pfizer Business Overview

11.12.3 Pfizer Hormone Sensitive Prostate Cancer Drugs Introduction

11.12.4 Pfizer Revenue in Hormone Sensitive Prostate Cancer Drugs Business (2021–2026)

11.12.5 Pfizer Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Novartis

Merc & Co.

Bristol myers

Dendreon Corporation

GlaxoSmithKline PLC

Ferring

Roche

Celgen

Amgen Inc

TEVA

Bayer

Pfizer Inc

Merc & Co.

List of Tables

Table 1. Global Hormone Sensitive Prostate Cancer Drugs Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Androgen Ablation Therapy

Table 3. Key Players of Anti-androgens

Table 4. Key Players of Chemotherapy

Table 5. Key Players of Targeted Therapy

Table 6. Global Hormone Sensitive Prostate Cancer Drugs Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 7. Global Hormone Sensitive Prostate Cancer Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 8. Global Hormone Sensitive Prostate Cancer Drugs Market Size by Region (US$ Million), 2021–2026

Table 9. Global Hormone Sensitive Prostate Cancer Drugs Market Share by Region (2021–2026)

Table 10. Global Hormone Sensitive Prostate Cancer Drugs Forecasted Market Size by Region (US$ Million), 2027–2032

Table 11. Global Hormone Sensitive Prostate Cancer Drugs Market Share by Region (2027–2032)

Table 12. Hormone Sensitive Prostate Cancer Drugs Market Trends

Table 13. Hormone Sensitive Prostate Cancer Drugs Market Drivers

Table 14. Hormone Sensitive Prostate Cancer Drugs Market Challenges

Table 15. Hormone Sensitive Prostate Cancer Drugs Market Restraints

Table 16. Global Hormone Sensitive Prostate Cancer Drugs Revenue by Players (US$ Million), 2021–2026

Table 17. Global Hormone Sensitive Prostate Cancer Drugs Market Share by Players (2021–2026)

Table 18. Global Top Hormone Sensitive Prostate Cancer Drugs Players by Tier (Tier 1, Tier 2, and Tier 3), based on Hormone Sensitive Prostate Cancer Drugs Revenue, 2025

Table 19. Ranking of Global Top Hormone Sensitive Prostate Cancer Drugs Companies by Revenue (US$ Million) in 2025

Table 20. Global 5 Largest Players Market Share by Hormone Sensitive Prostate Cancer Drugs Revenue (CR5 and HHI), 2021–2026

Table 21. Global Key Players of Hormone Sensitive Prostate Cancer Drugs, Headquarters and Area Served

Table 22. Global Key Players of Hormone Sensitive Prostate Cancer Drugs, Products and Applications

Table 23. Global Key Players of Hormone Sensitive Prostate Cancer Drugs, Date of General Availability (GA)

Table 24. Mergers and Acquisitions, Expansion Plans

Table 25. Global Hormone Sensitive Prostate Cancer Drugs Market Size by Type (US$ Million), 2021–2026

Table 26. Global Hormone Sensitive Prostate Cancer Drugs Revenue Market Share by Type (2021–2026)

Table 27. Global Hormone Sensitive Prostate Cancer Drugs Forecasted Market Size by Type (US$ Million), 2027–2032

Table 28. Global Hormone Sensitive Prostate Cancer Drugs Revenue Market Share by Type (2027–2032)

Table 29. Global Hormone Sensitive Prostate Cancer Drugs Market Size by Application (US$ Million), 2021–2026

Table 30. Global Hormone Sensitive Prostate Cancer Drugs Revenue Market Share by Application (2021–2026)

Table 31. Global Hormone Sensitive Prostate Cancer Drugs Forecasted Market Size by Application (US$ Million), 2027–2032

Table 32. Global Hormone Sensitive Prostate Cancer Drugs Revenue Market Share by Application (2027–2032)

Table 33. North America Hormone Sensitive Prostate Cancer Drugs Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 34. North America Hormone Sensitive Prostate Cancer Drugs Market Size by Country (US$ Million), 2021–2026

Table 35. North America Hormone Sensitive Prostate Cancer Drugs Market Size by Country (US$ Million), 2027–2032

Table 36. Europe Hormone Sensitive Prostate Cancer Drugs Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 37. Europe Hormone Sensitive Prostate Cancer Drugs Market Size by Country (US$ Million), 2021–2026

Table 38. Europe Hormone Sensitive Prostate Cancer Drugs Market Size by Country (US$ Million), 2027–2032

Table 39. Asia-Pacific Hormone Sensitive Prostate Cancer Drugs Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 40. Asia-Pacific Hormone Sensitive Prostate Cancer Drugs Market Size by Region (US$ Million), 2021–2026

Table 41. Asia-Pacific Hormone Sensitive Prostate Cancer Drugs Market Size by Region (US$ Million), 2027–2032

Table 42. Latin America Hormone Sensitive Prostate Cancer Drugs Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 43. Latin America Hormone Sensitive Prostate Cancer Drugs Market Size by Country (US$ Million), 2021–2026

Table 44. Latin America Hormone Sensitive Prostate Cancer Drugs Market Size by Country (US$ Million), 2027–2032

Table 45. Middle East & Africa Hormone Sensitive Prostate Cancer Drugs Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 46. Middle East & Africa Hormone Sensitive Prostate Cancer Drugs Market Size by Country (US$ Million), 2021–2026

Table 47. Middle East & Africa Hormone Sensitive Prostate Cancer Drugs Market Size by Country (US$ Million), 2027–2032

Table 48. Novartis Company Details

Table 49. Novartis Business Overview

Table 50. Novartis Hormone Sensitive Prostate Cancer Drugs Product

Table 51. Novartis Revenue in Hormone Sensitive Prostate Cancer Drugs Business (US$ Million), 2021–2026

Table 52. Novartis Recent Development

Table 53. Merc & Co. Company Details

Table 54. Merc & Co. Business Overview

Table 55. Merc & Co. Hormone Sensitive Prostate Cancer Drugs Product

Table 56. Merc & Co. Revenue in Hormone Sensitive Prostate Cancer Drugs Business (US$ Million), 2021–2026

Table 57. Merc & Co. Recent Development

Table 58. Bristol-Myers Company Details

Table 59. Bristol-Myers Business Overview

Table 60. Bristol-Myers Hormone Sensitive Prostate Cancer Drugs Product

Table 61. Bristol-Myers Revenue in Hormone Sensitive Prostate Cancer Drugs Business (US$ Million), 2021–2026

Table 62. Bristol-Myers Recent Development

Table 63. Dendreon Corporation Company Details

Table 64. Dendreon Corporation Business Overview

Table 65. Dendreon Corporation Hormone Sensitive Prostate Cancer Drugs Product

Table 66. Dendreon Corporation Revenue in Hormone Sensitive Prostate Cancer Drugs Business (US$ Million), 2021–2026

Table 67. Dendreon Corporation Recent Development

Table 68. GlaxoSmithKline Company Details

Table 69. GlaxoSmithKline Business Overview

Table 70. GlaxoSmithKline Hormone Sensitive Prostate Cancer Drugs Product

Table 71. GlaxoSmithKline Revenue in Hormone Sensitive Prostate Cancer Drugs Business (US$ Million), 2021–2026

Table 72. GlaxoSmithKline Recent Development

Table 73. Ferring Company Details

Table 74. Ferring Business Overview

Table 75. Ferring Hormone Sensitive Prostate Cancer Drugs Product

Table 76. Ferring Revenue in Hormone Sensitive Prostate Cancer Drugs Business (US$ Million), 2021–2026

Table 77. Ferring Recent Development

Table 78. Roche Company Details

Table 79. Roche Business Overview

Table 80. Roche Hormone Sensitive Prostate Cancer Drugs Product

Table 81. Roche Revenue in Hormone Sensitive Prostate Cancer Drugs Business (US$ Million), 2021–2026

Table 82. Roche Recent Development

Table 83. Celgen Company Details

Table 84. Celgen Business Overview

Table 85. Celgen Hormone Sensitive Prostate Cancer Drugs Product

Table 86. Celgen Revenue in Hormone Sensitive Prostate Cancer Drugs Business (US$ Million), 2021–2026

Table 87. Celgen Recent Development

Table 88. Amgen Company Details

Table 89. Amgen Business Overview

Table 90. Amgen Hormone Sensitive Prostate Cancer Drugs Product

Table 91. Amgen Revenue in Hormone Sensitive Prostate Cancer Drugs Business (US$ Million), 2021–2026

Table 92. Amgen Recent Development

Table 93. Teva Company Details

Table 94. Teva Business Overview

Table 95. Teva Hormone Sensitive Prostate Cancer Drugs Product

Table 96. Teva Revenue in Hormone Sensitive Prostate Cancer Drugs Business (US$ Million), 2021–2026

Table 97. Teva Recent Development

Table 98. Bayer Company Details

Table 99. Bayer Business Overview

Table 100. Bayer Hormone Sensitive Prostate Cancer Drugs Product

Table 101. Bayer Revenue in Hormone Sensitive Prostate Cancer Drugs Business (US$ Million), 2021–2026

Table 102. Bayer Recent Development

Table 103. Pfizer Company Details

Table 104. Pfizer Business Overview

Table 105. Pfizer Hormone Sensitive Prostate Cancer Drugs Product

Table 106. Pfizer Revenue in Hormone Sensitive Prostate Cancer Drugs Business (US$ Million), 2021–2026

Table 107. Pfizer Recent Development

Table 108. Research Programs/Design for This Report

Table 109. Key Data Information from Secondary Sources

Table 110. Key Data Information from Primary Sources

Table 111. Authors List of This Report

List of Figures

Figure 1. Hormone Sensitive Prostate Cancer Drugs Picture

Figure 2. Global Hormone Sensitive Prostate Cancer Drugs Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Hormone Sensitive Prostate Cancer Drugs Market Share by Type: 2025 vs 2032

Figure 4. Androgen Ablation Therapy Features

Figure 5. Anti-androgens Features

Figure 6. Chemotherapy Features

Figure 7. Targeted Therapy Features

Figure 8. Global Hormone Sensitive Prostate Cancer Drugs Market Size by Application (US$ Million), 2021–2032

Figure 9. Global Hormone Sensitive Prostate Cancer Drugs Market Share by Application: 2025 vs 2032

Figure 10. Hospitals Case Studies

Figure 11. Clinics Case Studies

Figure 12. Other Case Studies

Figure 13. Hormone Sensitive Prostate Cancer Drugs Report Years Considered

Figure 14. Global Hormone Sensitive Prostate Cancer Drugs Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 15. Global Hormone Sensitive Prostate Cancer Drugs Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 16. Global Hormone Sensitive Prostate Cancer Drugs Market Share by Region: 2025 vs 2032

Figure 17. Global Hormone Sensitive Prostate Cancer Drugs Market Share by Players in 2025

Figure 18. Global Hormone Sensitive Prostate Cancer Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 19. The Top 10 and 5 Players Market Share by Hormone Sensitive Prostate Cancer Drugs Revenue in 2025

Figure 20. North America Hormone Sensitive Prostate Cancer Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 21. North America Hormone Sensitive Prostate Cancer Drugs Market Share by Country (2021–2032)

Figure 22. United States Hormone Sensitive Prostate Cancer Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 23. Canada Hormone Sensitive Prostate Cancer Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 24. Europe Hormone Sensitive Prostate Cancer Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 25. Europe Hormone Sensitive Prostate Cancer Drugs Market Share by Country (2021–2032)

Figure 26. Germany Hormone Sensitive Prostate Cancer Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 27. France Hormone Sensitive Prostate Cancer Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. U.K. Hormone Sensitive Prostate Cancer Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. Italy Hormone Sensitive Prostate Cancer Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. Russia Hormone Sensitive Prostate Cancer Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. Ireland Hormone Sensitive Prostate Cancer Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. Asia-Pacific Hormone Sensitive Prostate Cancer Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 33. Asia-Pacific Hormone Sensitive Prostate Cancer Drugs Market Share by Region (2021–2032)

Figure 34. China Hormone Sensitive Prostate Cancer Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. Japan Hormone Sensitive Prostate Cancer Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. South Korea Hormone Sensitive Prostate Cancer Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. Southeast Asia Hormone Sensitive Prostate Cancer Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. India Hormone Sensitive Prostate Cancer Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Australia & New Zealand Hormone Sensitive Prostate Cancer Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. Latin America Hormone Sensitive Prostate Cancer Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 41. Latin America Hormone Sensitive Prostate Cancer Drugs Market Share by Country (2021–2032)

Figure 42. Mexico Hormone Sensitive Prostate Cancer Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. Brazil Hormone Sensitive Prostate Cancer Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Middle East & Africa Hormone Sensitive Prostate Cancer Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 45. Middle East & Africa Hormone Sensitive Prostate Cancer Drugs Market Share by Country (2021–2032)

Figure 46. Israel Hormone Sensitive Prostate Cancer Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. Saudi Arabia Hormone Sensitive Prostate Cancer Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. UAE Hormone Sensitive Prostate Cancer Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 49. Novartis Revenue Growth Rate in Hormone Sensitive Prostate Cancer Drugs Business (2021–2026)

Figure 50. Merc & Co. Revenue Growth Rate in Hormone Sensitive Prostate Cancer Drugs Business (2021–2026)

Figure 51. Bristol-Myers Revenue Growth Rate in Hormone Sensitive Prostate Cancer Drugs Business (2021–2026)

Figure 52. Dendreon Corporation Revenue Growth Rate in Hormone Sensitive Prostate Cancer Drugs Business (2021–2026)

Figure 53. GlaxoSmithKline Revenue Growth Rate in Hormone Sensitive Prostate Cancer Drugs Business (2021–2026)

Figure 54. Ferring Revenue Growth Rate in Hormone Sensitive Prostate Cancer Drugs Business (2021–2026)

Figure 55. Roche Revenue Growth Rate in Hormone Sensitive Prostate Cancer Drugs Business (2021–2026)

Figure 56. Celgen Revenue Growth Rate in Hormone Sensitive Prostate Cancer Drugs Business (2021–2026)

Figure 57. Amgen Revenue Growth Rate in Hormone Sensitive Prostate Cancer Drugs Business (2021–2026)

Figure 58. Teva Revenue Growth Rate in Hormone Sensitive Prostate Cancer Drugs Business (2021–2026)

Figure 59. Bayer Revenue Growth Rate in Hormone Sensitive Prostate Cancer Drugs Business (2021–2026)

Figure 60. Pfizer Revenue Growth Rate in Hormone Sensitive Prostate Cancer Drugs Business (2021–2026)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Hormone Refractory Prostate Cancer HRPCA Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Castration Resistant Prostate Cancer CRPC HRPCA Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Cancer Hormone Therapy Drugs Market Insights Forecast to 2030

Global Endocrine Therapy Medication Market Research Report 2024

Global Androgen Suppression Therapy Market Insights Forecast to 2030

Endocrine Therapy Drugs ETDs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Prostate Cancer Medicine Market Insights Forecast to 2030

Global Castration Resistant Prostate Cancer Treatment Market Research Report 2024

Global Gonadotropin releasing Hormone Antagonists Market Research Report 2024

Global Steroid Hormone Drugs Market Research Report 2024

Testosterone Blocker Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Castrate resistant Prostate Cancer Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Castration resistant Prostate Cancer Drugs Market Research Report 2025

Global Benign Prostatic Hypertrophy Medication Market Research Report 2024

Global Castrate Resistant Prostate Cancer Therapeutics Market Research Report 2025

Global Antihormonal Cancer Therapies Market Insights Forecast to 2030

Global Prostate Cancer Chemotherapy Drugs Market Research Report 2025

Global LHRH for Prostate Treatment Market Research Report 2024

Global Prostate Cancer Devices Market Research Report 2025

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions